01.12.2021 - In the Past Year, Sigyn Therapy Has Been Validated to Address a Broad-Spectrum of Inflammatory Mediators, Gram-Negative Bacterial Toxins, Gram-Positive Bacterial Toxins and Viral Pathogens SAN DIEGO, CA, Dec. 01, 2021 (GLOBE NEWSWIRE) - via . Seite 1
San Diego, California (Newsfile Corp. - August 23, 2021) - Sigyn Therapeutics, Inc. (OTC Pink: SIGY) today announced that Jim Joyce, Chairman & CEO will be attending the Q3 Virtual Investor Summit.